Overview A 2-Month Safety Follow-Up Trial Status: Completed Trial end date: 2008-09-01 Target enrollment: Participant gender: Summary The main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or MKC-TI-030) for an additional 2-month safety follow-up. Details Lead Sponsor: Mannkind CorporationTreatments: InsulinInsulin, Globin Zinc